2 New Drugs May Fight Multiple Sclerosis

Two new oral drugs cut by about half the relapse rate in people with multiple sclerosis (MS). If approved by the FDA, the drugs -- cladribine and fingolimod -- would become the first treatments for MS that don't involve regular injections or infusions.